» Articles » PMID: 19759158

Mutations in the Thumb Allow Human Immunodeficiency Virus Type 1 Reverse Transcriptase to Be Cleaved by Protease in Virions

Overview
Journal J Virol
Date 2009 Sep 18
PMID 19759158
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Although human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) has been extensively studied, there are still significant questions about the effects of mutations on the maturation and stability of RT. We show here that a significant fraction (>80%) of the single point mutations we generated in the thumb subdomain of HIV-1 (RT) affect the stability of RT in virions. Fragments of the unstable mutant RTs can be detected in Western blots of virion proteins; however, the degree of degradation varies. The titers of the mutants whose virions contain degraded RTs are reduced. Some, but not all, of the unstable RT thumb subdomain mutants we analyzed have a temperature-sensitive phenotype. A preliminary survey of mutations in other subdomains of RT shows that some of these mutations also destabilize RT. The stability of the RT mutants is enhanced by the addition of a protease inhibitor, suggesting that the viral protease plays an important role in the degradation of the mutant RTs. These results confirm and extend earlier reports of mutations that affect the stability of RT in virions. The data suggest that the stability of a mutant RT in virions could be a major factor in determining the virus titer and, by extension, viral fitness, which could affect whether a mutation in RT is acceptable to the virus.

Citing Articles

HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.

Hsieh S, Yu F, Huang K, Wang C J Virol. 2023; 97(9):e0094823.

PMID: 37671867 PMC: 10537780. DOI: 10.1128/jvi.00948-23.


Large Multidomain Protein NMR: HIV-1 Reverse Transcriptase Precursor in Solution.

Ilina T, Xi Z, Brosenitsch T, Sluis-Cremer N, Ishima R Int J Mol Sci. 2020; 21(24).

PMID: 33333923 PMC: 7765405. DOI: 10.3390/ijms21249545.


Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.

Ojwach D, Madlala P, Gordon M, Ndungu T, Mann J Virology. 2020; 554:1-8.

PMID: 33316731 PMC: 7931244. DOI: 10.1016/j.virol.2020.12.003.


Two Coselected Distal Mutations in HIV-1 Reverse Transcriptase (RT) Alter Susceptibility to Nonnucleoside RT Inhibitors and Nucleoside Analogs.

Boyer P, Melody K, Smith S, Dunn L, Kline C, Fischer D J Virol. 2019; 93(11).

PMID: 30894467 PMC: 6532099. DOI: 10.1128/JVI.00224-19.


Reverse Transcription of Retroviruses and LTR Retrotransposons.

Hughes S Microbiol Spectr. 2015; 3(2):MDNA3-0027-2014.

PMID: 26104704 PMC: 6775776. DOI: 10.1128/microbiolspec.MDNA3-0027-2014.


References
1.
Olivares I, Mulky A, Boross P, Tozser J, Kappes J, Lopez-Galindez C . HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions. J Mol Biol. 2007; 372(2):369-81. PMC: 2696282. DOI: 10.1016/j.jmb.2007.06.073. View

2.
Deeks S, Hoh R, Neilands T, Liegler T, Aweeka F, Petropoulos C . Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection. J Infect Dis. 2005; 192(9):1537-44. DOI: 10.1086/496892. View

3.
Huang M, Zensen R, Cho M, Martin M . Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant. J Virol. 1998; 72(3):2047-54. PMC: 109498. DOI: 10.1128/JVI.72.3.2047-2054.1998. View

4.
Tang S, Murakami T, Agresta B, Campbell S, Freed E, LEVIN J . Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. J Virol. 2001; 75(19):9357-66. PMC: 114504. DOI: 10.1128/JVI.75.19.9357-9366.2001. View

5.
Wapling J, Moore K, Sonza S, Mak J, Tachedjian G . Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer. J Virol. 2005; 79(16):10247-57. PMC: 1182633. DOI: 10.1128/JVI.79.16.10247-10257.2005. View